These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 34482818)
1. The regulatory pattern of target gene expression by aberrant enhancer methylation in glioblastoma. Zhao X; Ji J; Wang S; Wang R; Yu Q; Li D BMC Bioinformatics; 2021 Sep; 22(1):420. PubMed ID: 34482818 [TBL] [Abstract][Full Text] [Related]
2. Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma. Ji J; Zhao L; Zhao X; Li Q; An Y; Li L; Li D Int J Mol Med; 2020 Jul; 46(1):224-238. PubMed ID: 32319552 [TBL] [Abstract][Full Text] [Related]
3. Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma. Liu Z; Wang X; Yang G; Zhong C; Zhang R; Ye J; Zhong Y; Hu J; Ozal B; Zhao S J Cell Biochem; 2020 Jul; 121(7):3502-3515. PubMed ID: 32277520 [TBL] [Abstract][Full Text] [Related]
4. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme. Li Q; Dong C; Cui J; Wang Y; Hong X J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874 [TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma. Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808 [TBL] [Abstract][Full Text] [Related]
6. Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma. Li M; Long S; Hu J; Wang Z; Geng C; Ou S Aging (Albany NY); 2019 Nov; 11(21):9405-9423. PubMed ID: 31692451 [TBL] [Abstract][Full Text] [Related]
7. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells. Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-149 is epigenetically silenced tumor-suppressive microRNA, involved in cell proliferation and downregulation of AKT1 and cyclin D1 in human glioblastoma multiforme. Ghasemi A; Fallah S; Ansari M Biochem Cell Biol; 2016 Dec; 94(6):569-576. PubMed ID: 27783537 [TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792 [TBL] [Abstract][Full Text] [Related]
10. Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastoma. Wen WS; Hu SL; Ai Z; Mou L; Lu JM; Li S J Cell Physiol; 2017 Dec; 232(12):3622-3630. PubMed ID: 28145562 [TBL] [Abstract][Full Text] [Related]
11. Identification of hub genes and regulatory factors of glioblastoma multiforme subgroups by RNA-seq data analysis. Li Y; Min W; Li M; Han G; Dai D; Zhang L; Chen X; Wang X; Zhang Y; Yue Z; Liu J Int J Mol Med; 2016 Oct; 38(4):1170-8. PubMed ID: 27572852 [TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531 [TBL] [Abstract][Full Text] [Related]
13. An epigenetic biomarker panel for glioblastoma multiforme personalized medicine through DNA methylation analysis of human embryonic stem cell-like signature. Chiang JH; Cheng WS; Hood L; Tian Q OMICS; 2014 May; 18(5):310-23. PubMed ID: 24601786 [TBL] [Abstract][Full Text] [Related]
14. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
15. Identification and validation of DNA methylation-driven gene PCDHB4 as a novel tumor suppressor for glioblastoma diagnosis and prognosis. Huang H; Xie Y; Chen X; Zhang D; Zhang X; Deng Y; Huang Z; Bi H; Hu X; Yan X; Liang H; Lv Z; Sun X; Zhang M; Hu D; Hu F Mol Carcinog; 2023 Dec; 62(12):1832-1845. PubMed ID: 37560880 [TBL] [Abstract][Full Text] [Related]
16. An update on the epigenetics of glioblastomas. Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647 [TBL] [Abstract][Full Text] [Related]
17. Construction of Novel DNA Methylation-Based Prognostic Model to Predict Survival in Glioblastoma. Zhao J; Wang L; Kong D; Hu G; Wei B J Comput Biol; 2020 May; 27(5):718-728. PubMed ID: 31460783 [TBL] [Abstract][Full Text] [Related]
18. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples. Mukherjee S Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845 [TBL] [Abstract][Full Text] [Related]
19. Homeobox genes gain trimethylation of histone H3 lysine 4 in glioblastoma tissue. Luo K; Luo D; Wen H Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27160082 [TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of CPS1 in glioblastoma multiforme. Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]